Abstract OBJECTIVE: To explore possible correlations between renal Th1/Th2 ratio and renal microvascular injury in children with Henoch-Schonlein purpura nephritis (HSPN). METHODS: Thirty-two children with HSPN were enrolled. They were classified into four groups by renal pathology: HSPN class II (n=8), HSPN class IIIa (n=7), HSPN class IIIb (n=10) and HSPN class IV/V (n=7). Five patients undergoing nephrectomy due to trauma were used as the controls. INFγ, IL-4 and CD34 in the renal tissues were measured by immunohistochemical analysis. INFγ was used as a marker of Th1, IL-4 was used as a marker of Th2 and CD34 was used as a marker of microvessel. The renal microvessel density was evaluated according to the Weidner standard. The relationships among the local Th1/Th2 ratio, renal pathological grade, microvessel score and microvessel density were studied. RESULTS: Immunohistochemical analysis showed a lower expression of INFγ and a higher expression of IL-4 in the HSPN groups than in the control group. The local Th1/Th2 ratio in the HSPN groups decreased and correlated significantly with the renal pathological grade. There were significant differences among four HSPN subgroups (P<0.05). Compared with the control group, the renal microvessel density in the HSPN class II and class IIIa groups increased significantly (P<0.05), but it decreased in the HSPN class IV/V group (P<0.05). The renal microvessel scores in the HSPN class IIIa, class IIIb and class IV/V groups increased significantly compared with those in the control and the HSPN classⅡ. The increased renal microvessel scores were associated with more severe renal pathological changes. A negative correlation was found between the local Th1/Th2 ratio and the microvessel density in kidneys (r=-0.921, P<0.01). CONCLUSIONS: The decrease of Th1/Th2 ratio in kidneys might be responsible for renal microvascular injury in children with HSPN.
HUANG Dan-Lin,XU Zi-Chuan,DANG Xi-Qiang et al. Relationship between renal Th1/Th2 ratio and renal microvascular injury in children with Henoch-Schonlein purpura nephritis[J]. 中国当代儿科杂志, 2011, 13(4): 273-277.
HUANG Dan-Lin,XU Zi-Chuan,DANG Xi-Qiang et al. Relationship between renal Th1/Th2 ratio and renal microvascular injury in children with Henoch-Schonlein purpura nephritis[J]. CJCP, 2011, 13(4): 273-277.
［1］Del Prete G. The concept of type-1 and type-2 helper T cells and their cytokines in humans［J］.Int Rev Immunol, 1998, 16(3-4): 427-455.
［2］Jancovic D, Liu Z, Gause WC. Th1-and Th2-cell commitment during infectious disease: asymmetry in divergent pathways［J］.Trends Immunol, 2001, 22(8): 450-457.
［3］Qin W, Hongya W, Yongjing C, Fang X, Yue M, Xuekun Z, et al. Increased OX40 and soluble OX40 ligands in children with Henoch-Schonlein purpura: association with renal involvement［J］. Pediatr Allergy Immunol, 2011, 22（1 Pt 1）: 54-59.
［11］Kaneyama T, Kobayashi S, Aoyagi D, Ehara T. Tranilast modulates fibrosis, epithelial-mesenchymal transition and peritubular capillary injury in unilateral ureteral obstruction rats［J］. Pathology, 2010, 42(6): 564-573.
［12］Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, et al. Role of The microvascular endothelium in progressive renal disease［J］. J Am Soc Nephrol, 2002, 13(3): 806-816.
［13］Wu L, Tiwari MM, Messer KJ, Holthoff JH, Gokden N, Brock RW, et al. Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice［J］. Am J Physiol Renal Physiol, 2007, 292(1): F261-F268.
［14］Ohashi R, Kitamura H, Yamanaka N. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats［J］. J Am Soc Nephrol, 2000, 11(1): 47-56.
［16］Mosmann TR, Coffman Rl. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties［J］.Annu Rev Immunol, 1989, 7: 145-173.
［17］Yano T, Tanikawa S, Fujie T, Masutani M, Horie T. Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer［J］. Eur J Cancer, 2000, 36(5): 601-609.
［18］Weidner N. Tumoural vascularity as a prognostic in cancer patients: the evidence continues to grow［J］. J Pathol, 1998, 184(2):119-122.
3.0.CO;2-D target="_blank">
